Global Gene Editing Market to reach $7.5bn by 2024 - PowerPoint PPT Presentation

About This Presentation

Global Gene Editing Market to reach $7.5bn by 2024


Get more details @ Major industry participants for the global gene editing market share include Agilent Technologies, Allele Biotech, AstraZeneca, Bio Rad, Cellectis, CRISPR Therapeutics, Editas Medicine, GE Healthcare Dharmacon, Lonza, Qiagen, Recombinetics, Sigma-Aldrich and Thermo Fisher Scientific. – PowerPoint PPT presentation

Number of Views:46


Transcript and Presenter's Notes

Title: Global Gene Editing Market to reach $7.5bn by 2024

Gene Editing Market share to reach 7.5bn by
2024 Global Market Insights Inc.
Fuel Cell Market size worth 25.5bn by 2024
Key Insights from Gene Editing Market
  • Gene Editing Market size is driven by rising
    number of biotechnology and pharmaceutical firms
    that will provide heavy revenue generating
  • According to Global Market Insights, Inc. Global
    gene editing market size worth USD 2.17 billion
    in 2015, is estimated to witness a CAGR of 14
    over the period of 2016-2024.
  • The rapid technological advancements in
    healthcare industry will also build a profitable
    roadmap for the gene-editing industry.
  • The pharmaceutical industry is also actively
    collaborating with the gene editing firms to
    implement the technology use in clinical
    development. In addition to this, the industry
    will gain wide acceptance on account of its
    benefits in the wellbeing of humans, animals, and
    plant ecosystems.
  • Gene editing industry finds a varied set of
    applications across areas such as oncology,
    muscular disorders, infectious disease, and

  • Hematology led the application landscape with a
    revenue of USD 807 million in 2015. Rising
    prevalence of infectious diseases such as HIV
    will promote the gene editing industry size in
    infectious disease applications, with a revenue
    estimation of USD 2.5 billion by 2024.
  • CRISPR/Cas9 is the most prominent technology
    implemented in the gene editing applications and
    has been the most buzzed topic among the
    researchers worldwide.
  • The major end-users participating in the gene
    editing market include CROs (Contract Research
    Organizations), Biotech Pharma companies, and
    Research Institutes.
  • Considering the global trends, US gene editing
    industry led the global landscape, with a revenue
    of USD 518 million in 2015.
  • UK gene editing market is anticipated to surpass
    USD 744 million by 2024, driven by the growing
    geriatric population base and frequent occurrence
    of chronic ailments across Europe.

  • Asia Pacific will also exhibit substantial growth
    over the coming years. Improving healthcare
    infrastructure, technological developments in the
    medical space, rising geriatric population base,
    and favorable government norms will stimulate the
    APAC market growth.
  • The emerging economies will gain a major traction
    of the industry players to expand the regional
  • Key market participants include Agilent
    Technologies, AstraZeneca, Allele Biotech,
    Cellectis, Bio Rad, Editas Medicine, CRISPR
    Therapeutics, Lonza, GE Healthcare Dharmacon,
    Recombinetics, Inc., Qiagen, Thermo Fisher
    Scientific, and Sigma-Aldrich.

U.S. Gene Editing Market Size, by Application,
2013- 2024 (USD Million)

Table of Contents
Chapter 1. Methodology and Scope 1.1
Research Methodology 1.1.1 Initial
data exploration 1.1.2 Statistical modeling and
forecast 1.1.3 Industry insights and
validation 1.1.4 Research scope and assumptions
List of Data Sources 1.2.1 Primary
sources 1.2.2 Secondary sources Chapter 2.
Executive Summary 2.1 Gene Editing industry
3600 synopsis, 2013 - 2024 2.1.1 Business
trends 2.1.2 Application trends 2.1.3
Technology trends 2.1.4 End User trends 2.1.5
Regional trends
Table of Contents
Chapter 3. Gene Editing Industry Insights 3.1
Industry segmentation 3.2 Industry size and
future growth prospects, 2013 2024 3.3
Industry ecosystem analysis 3.3.1 Vendor
matrix 3.4 Industry dynamics 3.4.1 Growth
drivers Increased funding for
genetics research Increased RD
expenditure and growth of biotechnology
Increasing demand for synthetic
genes Growing use of genetically
modified technology Technology
advancements 3.4.2 Industry pitfalls
challenges Stringent government
regulations Dearth of public
Table of Contents
3.5 Regulatory trends 3.5.1 U.S. 3.5.2
Europe 3.5.3 China 3.6 Key growth
opportunities 3.7 Company market share
analysis, 2015 3.7.1 Strategy dashboard 3.8
Porters analysis 3.9 PESTEL analysis

Browse Full Market Research Report On Gene
Editing Market _at_ http//
Request for a Sample of this Research Report
_at_ https//
/810 https//
Stay In Touch Website Soci
al Media
Write a Comment
User Comments (0)